FDA may permit Rx-to-OTC switch using additional conditions beyond traditional labeling | Hogan Lovells
On June 27, the U.S. Food and Drug Administration (FDA) published the long-awaited proposed rule “Nonprescription Drug Product with an Additional Condition for Nonprescription Use”...
Source: jdsupra.com